13F

Stock

Alnylam Pharmaceuticals, Inc.

ALNY · held by 5 managers

Reported value

$42.8M

Holders

5

+0 new · −1 exited

Holders’ est. mark

$2.82M

Price effect on 4 books still in the name

Largest holder

$27.2M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC142K$27.2M$2.03MCut−$1.54M
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main12.8M$12.6M$735.4KAdded$982.3K
Aware Super Pty Ltd as trustee of Aware Super5.87K$2.33MHeld
Swiss Life Asset Management Ltd3.41K$653.8K$50.4KCut−$87.2K
Leonteq Securities AG442$84.6K$6.33KCut−$18.6K

Who left

Positions as of Q4 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.